SCHEMBL41938

SCHEMBL41938

CNC(CCCCN(C(=O)O)C(C)(C)C)c1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.44
LMNA P02545 3/20 0.40
ALDH1A1 P00352 2/20 0.40
TSHR P16473 2/20 0.40
CYP3A4 P08684 1/20 0.40
KDM4E B2RXH2 1/20 0.40
RAB9A P51151 1/20 0.40
CHRM2 P08172 5/20 0.38
SLC6A2 P23975 5/20 0.38
SLC6A4 P31645 5/20 0.38
SCN1A P35498 3/20 0.38
SCN2A Q99250 3/20 0.38
SCN3A Q9NY46 3/20 0.38
CYP1A2 P05177 1/20 0.37
PMP22 Q01453 2/20 0.36
BLM P54132 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.35
KCNH2 Q12809 5/20 0.35
KCNA5 P22460 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28622173 0.77 ALDH1A1 (0.46) CYP2C19LMNAALDH1A1TSHRCYP3A4
SCHEMBL39931 0.74 MAPT (0.48) ALDH1A1CYP3A4KDM4ENPSR1POLB
SCHEMBL1529808 0.73 HTR1D (0.40) ALDH1A1KDM4ESLC6A3L3MBTL1OPRK1
SCHEMBL40517 0.73 HRH1 (0.42) TSHRCHRM2SLC6A2SLC6A4SCN1A
SCHEMBL3799389 0.73 SMN1; SMN2 (0.47) LMNAALDH1A1TSHRKDM4ERAB9A
SCHEMBL3799393 0.73 SMN1; SMN2 (0.47) LMNAALDH1A1TSHRKDM4ERAB9A
SCHEMBL3717619 0.72 LMNA (0.40) CYP2C19LMNAALDH1A1TSHRCYP3A4
SCHEMBL635767 0.72 CYP2C19 (0.39) CYP2C19LMNAALDH1A1TSHRCYP3A4
SCHEMBL43167 0.72 CTNNB1 (0.47) CYP2C19LMNAALDH1A1CYP1A2POLB
Hydrochloric Acid SCHEMBL42821 0.72 CXCR4 (0.41) LMNAALDH1A1TSHRCHRM2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE MSD K.K 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028990-A1 3 ARYL OR HETEROARYL-SUBSTITUTED INDOLE DERIVATIVE IDO1, TPH1, AHR CYP2C19 381/4885LMNA 1992/4885ALDH1A1 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.